Alpha Dna Investment Management LLC United Therapeutics Corp Transaction History
Alpha Dna Investment Management LLC
- $257 Million
- Q4 2024
A detailed history of Alpha Dna Investment Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 2,255 shares of UTHR stock, worth $719,006. This represents 0.31% of its overall portfolio holdings.
Number of Shares
2,255
Previous 2,092
7.79%
Holding current value
$719,006
Previous $749,000
6.14%
% of portfolio
0.31%
Previous 0.29%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.84 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.74 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.42 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$880 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$786 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...